Proteins that function as morpheeins are illustrated using a dice analogy where one dice can morph into two different shapes, cubic and tetrahedral. The illustrated assemblies apply a rule that the dice face with one spot must contact the dice face with four spots. To satisfy the rule for each dice in an assembly, the cubic dice can only form a tetramer and the tetrahedral dice can only assemble to a pentamer. This is analogous to two different conformations (morpheein forms) of a protein subunit each dictating assembly to a different oligomer. All dice in one assembly must be of the same shape before assembly. Thus, for example, the tetramer must come apart, and its component dice must change shape to a pyramid before they can participate in assembly into a pentamer.
Morpheeins are proteins that can form two or more different homo-oligomers (morpheein forms), but must come apart and change shape to convert between forms. The alternate shape may reassemble to a different oligomer. The shape of the subunit dictates which oligomer is formed.[1][2] Each oligomer has a finite number of subunits (stoichiometry). Morpheeins can interconvert between forms under physiological conditions and can exist as an equilibrium of different oligomers. These oligomers are physiologically relevant and are not misfolded protein; this distinguishes morpheeins from prions and amyloid. The different oligomers have distinct functionality. Interconversion of morpheein forms can be a structural basis for allosteric regulation, an idea noted many years ago,[3][4] and later revived.[1][2][5][6] A mutation that shifts the normal equilibrium of morpheein forms can serve as the basis for a conformational disease.[7] Features of morpheeins can be exploited for drug discovery.[1][5][8] The dice image (Fig 1) represents a morpheein equilibrium containing two different monomeric shapes that dictate assembly to a tetramer or a pentamer. The one protein that is established to function as a morpheein is porphobilinogen synthase,[2][9][10] though there are suggestions throughout the literature that other proteins may function as morpheeins (for more information see "Table of Putative Morpheeins" below).
^ abcJaffe, Eileen K. (2005). "Morpheeins – a new structural paradigm for allosteric regulation". Trends in Biochemical Sciences. 30 (9): 490–7. doi:10.1016/j.tibs.2005.07.003. PMID 16023348.
^ abcBreinig, Sabine; Kervinen, Jukka; Stith, Linda; Wasson, Andrew S; Fairman, Robert; Wlodawer, Alexander; Zdanov, Alexander; Jaffe, Eileen K (2003). "Control of tetrapyrrole biosynthesis by alternate quaternary forms of porphobilinogen synthase". Nature Structural Biology. 10 (9): 757–63. doi:10.1038/nsb963. PMID 12897770. S2CID 24188785.
^Cite error: The named reference Frieden67 was invoked but never defined (see the help page).
^Cite error: The named reference Nichol67 was invoked but never defined (see the help page).
^ abLawrence, Sarah H.; Ramirez, Ursula D.; Tang, Lei; Fazliyez, Farit; Kundrat, Lenka; Markham, George D.; Jaffe, Eileen K. (2008). "Shape Shifting Leads to Small-Molecule Allosteric Drug Discovery". Chemistry & Biology. 15 (6): 586–96. doi:10.1016/j.chembiol.2008.04.012. PMC 2703447. PMID 18559269.
^Selwood, Trevor; Jaffe, Eileen K. (2012). "Dynamic dissociating homo-oligomers and the control of protein function". Archives of Biochemistry and Biophysics. 519 (2): 131–43. doi:10.1016/j.abb.2011.11.020. PMC 3298769. PMID 22182754.
^Jaffe, Eileen K.; Stith, Linda (2007). "ALAD Porphyria is a Conformational Disease". The American Journal of Human Genetics. 80 (2): 329–37. doi:10.1086/511444. PMC 1785348. PMID 17236137.
^Jaffe, Eileen K. (2010). "Morpheeins – A New Pathway For Allosteric Drug Discovery". The Open Conference Proceedings Journal. 1: 1–6. doi:10.2174/2210289201001010001 (inactive 2024-03-28). PMC 3107518. PMID 21643557.{{cite journal}}: CS1 maint: DOI inactive as of March 2024 (link)
^Tang, L.; Stith, L; Jaffe, EK (2005). "Substrate-induced Interconversion of Protein Quaternary Structure Isoforms". Journal of Biological Chemistry. 280 (16): 15786–93. doi:10.1074/jbc.M500218200. PMID 15710608.
^Jaffe, Eileen K.; Lawrence, Sarah H. (2012). "Allostery and the dynamic oligomerization of porphobilinogen synthase". Archives of Biochemistry and Biophysics. 519 (2): 144–53. doi:10.1016/j.abb.2011.10.010. PMC 3291741. PMID 22037356.
Morpheeins are proteins that can form two or more different homo-oligomers (morpheein forms), but must come apart and change shape to convert between...
propagated to all subunits The morpheein model of allosteric regulation is a dissociative concerted model. A morpheein is a homo-oligomeric structure...
hyperinsulinism-hyperammonemia syndrome. Allosteric regulation: This protein may use the morpheein model of allosteric regulation. Allosteric inhibitors: Guanosine triphosphate...
enhancement of pro-inflammatory responses in cells. This protein may use the morpheein model of allosteric regulation. TNF was thought to be produced primarily...
(Lactuca sativa). PPO is listed as a morpheein, a protein that can form two or more different homo-oligomers (morpheein forms), but must come apart and change...
suspected to act as a mitogen for fibroblast lines. Tryptase may use the morpheein model of allosteric regulation. Mast cell tryptase-6 is involved in Trichinella...
mammalian monomers, possessing 2 similar domains). This protein may use the morpheein model of allosteric regulation. PFK is about 300 amino acids in length...
participate in glycolysis or gluconeogenesis. This protein may use the morpheein model of allosteric regulation. Glycerol Kinase (alternative name, ATP:glycerol...
WikiPathways: "GlycolysisGluconeogenesis_WP534". This protein may use the morpheein model of allosteric regulation. Ethanol is dehydrogenated to acetaldehyde...
AdoHcyase binds one NAD+ cofactor per subunit. This protein may use the morpheein model of allosteric regulation. Overall hydrolysis begins with dehydrogenative...
from uracil and phosphoribosylpyrophosphate. This protein may use the morpheein model of allosteric regulation. Selwood T, Jaffe EK (March 2012). "Dynamic...
ligase and hydrolase activity respectively. This protein may use the morpheein model of allosteric regulation. GRCh38: Ensembl release 89: ENSG00000062485...
dihydrobiopterin (qBH2), which is then reduced to BH4. PAH is proposed to use the morpheein model of allosteric regulation. Mammalian PAH exists in an equilibrium...
bacteria, and higher plants. Some varieties of this protein may use the morpheein model of allosteric regulation. This enzyme belongs to the family of isomerases...
condition adenylosuccinate lyase deficiency. This protein may use the morpheein model of allosteric regulation. Adenylosuccinate lyase (ASL) is an enzyme...
which leads to cell death. Type I L-asparaginase protein may use the morpheein model of allosteric regulation. The discovery and development of asparaginase...
biosynthesis of steroids and terpenoid biosynthesis. This protein may use the morpheein model of allosteric regulation. As of late 2007, two structures have been...
consequently p53R2 serves a major factor in dNTP supply. RNR may use the morpheein model of allosteric regulation. Generally Class I RNR inhibitors can be...
intermediate that is stabilized by nearby Lys41. This protein may use the morpheein model of allosteric regulation. Ribonuclease Raines RT (1998). "Ribonuclease...
enzyme participates in terpenoid biosynthesis. This protein may use the morpheein model of allosteric regulation. As of late 2007, two structures have been...
than the binding of substrates to the enzyme. This protein may use the morpheein model of allosteric regulation. Human CBS performs a crucial step in the...
site, is involved in interacting with gyrase. This protein may use the morpheein model of allosteric regulation. Glutamate racemase has emerged as a potential...
Global Information